PlexusDx believes that precision-guided treatment means looking beyond the medication label to understand your unique metabolic predispositions, genetic factors, and how they may influence drug tolerability and safety
Regular InBody scans help monitor whether weight changes are coming from fat loss rather than muscle loss, allowing providers to adjust treatment if needed
It could be related to stress, hormone levels, or even a heart or vascular condition
GLP-1 agonists may improve metabolic aspects but remain off-label for this indication
We commonly treat illnesses such as flu, strep throat, allergies, asthma, stomach flu, and ear infections
Albemarle is uniquely positioned to support the rapid growth of GLP-1 therapies, with facilities located near key innovation hubs driving this transformation